Judita Kinkorová

Dr. Judita Kinkorová

orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2015 in EPMA Journal
Verified
Journal Article
Open access
PDF file
JKJudita Kinkorová
Judita Kinkorová
Biobanks are an important compound of personalized medicine and strongly support the scientific progress in stratification of population and biomarker disc

7 April 2014 in EPMA Journal
Verified
Journal Article
Open access
PDF file
OGOlga Golubnitschaja
Olga Golubnitschaja
JKJudita Kinkorová
Judita Kinkorová
VCVincenzo Costigliola
Vincenzo Costigliola
The European Association for Predictive, Preventive and Personalised Medicine (EPMA) considers acute problems in medical sciences as well as the quality and management of medical services challenging health care systems in Europe and worldwide. This actuality has motivated the representatives of EPMA to comment on the efforts in promoting an integrative approach based on multidisciplinary expertise to advance health care-related research and management. The current paper provides a global overview of the problems related to medical services: pandemic scenario in the progression of common non-communicable diseases, delayed interventional approaches of reactive medicine, poor economy of health care systems, lack of specialised educational programmes, problematic ethical aspects of several treatments as well as inadequate communication among professional groups and policymakers. In the form of individual paragraphs, the article presents a consolidated position of PPPM professionals towards the new European programme ‘Horizon 2020’ providing the long-lasting instruments for scientific and technological progress in medical services and health care-related programmes. In the author's opinion, Horizon 2020 provides unlimited room for research and implementation in Predictive, Preventive and Personalised Medicine. However, the overall success of the programme strongly depends on the effective communication and consolidation of professionals relevant for PPPM as well as the communication quality with policymakers. Smart political decision is the prerequisite of the effective PPPM implementation in the health care sector. This position is focused on the patients' needs, innovative medical sciences, optimal health and disease management, expert recommendations for the relevant medical fields and optimal solutions which have a potential to advance health care services if the long-term strategies were to be effectively implemented as proposed here.

1 December 2015 in EPMA Journal
Verified
Journal Article
Open access
PDF file
HRHans-Peter Brunner-La Rocca
Hans-Peter Brunner-La Rocca
LFLutz Fleischhacker
Lutz Fleischhacker
OGOlga Golubnitschaja
Olga Golubnitschaja
FHFrank Heemskerk
Frank Heemskerk
THThomas Helms
Thomas Helms
BZBettina Zippel-Schultz
Bettina Zippel-Schultz
Chronic diseases are the leading causes of morbidity and mortality in Europe, accounting for more than 2/3 of all death causes and 75 % of the healthcare costs. Heart failure is one of the most...


23 November 2018 in EPMA Journal
Verified
Journal Article
Open access
PDF file
JKJudita Kinkorová
Judita Kinkorová
OTOndřej Topolčan
Ondřej Topolčan
Biobanks have during last two decades gained an important role in the whole process of biomedical research and health care not only in Europe but also worldwide. Biobanks are one of the pillars in personalised medicine tackling all its aspects such as prevention, diagnosis, treatment and monitoring closely the specific characteristics of an individual patient. The current and future power of biobanks is the amount of samples of high-quality and related information available for current and future research of diseases, for optimising patients´ prevention, diagnosis, treatment and monitoring. The material stored in biobanks is a treasure for future technologies that will be able to utilise the currently uncovered information and knowledge. A great and growing number of samples and related information also opens new ways in how to tackle the big data problems and population studies. Biobanks play a substantial role in drug discovery, development and validation. Biobanks are not only an issue of biomedical research, but are becoming a public issue involving patients, to actively participate in biobanking with respect to ethical, legal and social issues. And, finally, biobanking as a multidisciplinary and modern field of science requires appropriate education at all levels of society. To be a world leader in the field of biobanking requires wide international and interdisciplinary collaboration. The topic-dedicated programmes released by the European Commission sustainably support biobank development in Europe and the main tool is the biggest European Union (EU) research and innovation programme ever—Horizon 2020. This article reviews the main Horizon 2020 biobanking projects, financing schemes and the future perspectives.

10 March 2021 in EPMA Journal
Verified
Journal Article
Closed access
PDF file
JKJudita Kinkorová
Judita Kinkorová